Lenox Wealth Advisors’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

Lenox Wealth Advisors’s Portfolio DRTX Stock Details DRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-11,000	Closed	-$139K	–	354
2014 Q3	$139K	Buy	11,000 +3,000	+38%	+$44.8K	0.06%	35
2014 Q2	$129K	Hold	8,000	–	–	0.06%	31
2014 Q1	$114K	Hold	8,000	–	–	0.07%	31
2013 Q4	$102K	Hold	8,000	–	–	0.07%	39
2013 Q3	$72K	Hold	8,000	–	–	0.07%	26
2013 Q2	$58K	Buy	+8,000	New	+$58.7K	0.07%	32

Lenox Wealth Advisors's DRTX Position: Q4 2014 in Review

Lenox Wealth Advisors sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q4 2014, closing a stake of 11,000 shares — an estimated $139K sold.

Lenox Wealth Advisors first reported a position in DRTX in Q2 2013 and held it in 6 quarters. The position peaked at $139K in Q3 2014. 0 funds tracked by Wall St. Rank hold DRTX as of Q4 2014.

Lenox Wealth Advisors reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q4 2014 after selling out during the quarter.
Lenox Wealth Advisors sold 11,000 DURATA THERAPEUTICS INC COM STK (DE) shares in Q4 2014, an estimated $139K.
Lenox Wealth Advisors first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 6 quarters.
Lenox Wealth Advisors's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $139K in Q3 2014.
0 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q4 2014.

Based on Lenox Wealth Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.